Serina Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights
HUNTSVILLE, Aug. 09, 2024 (GLOBE NEWSWIRE) — Serina Therapeutics (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ […]